Exagen Inc. (NASDAQ: XGN) Stock Information | RedChip

Exagen Inc. (NASDAQ: XGN) Listen to this Section


$3.12
+0.2900 ( +10.25% ) 143.4K

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Market Data


Open


$3.12

Previous close


$2.83

Volume


143.4K

Market cap


$54.59M

Day range


$2.64 - $3.21

52 week range


$1.30 - $3.71

Insider Ownership Transactions

Total Amount Purchased: -284,200.00 | $ -886,704.00

Date Type Amount Purchased Purchaser
2024-06-14 Sale -15000.00 KAHN SCOTT D
2024-06-12 Sale -9000.00 Stokes Frank
2024-06-12 Sale -9000.00 Kim Paul
2024-06-12 Sale -13500.00 Nova Tina Susan
2024-06-12 Sale -9000.00 Hooker Ana
2024-05-16 Buy 40401.00 ABALLI JOHN
2024-03-06 Sale -9297.00 Adawi Kamal
2024-03-04 Sale -9804.00 ABALLI JOHN
2024-02-22 Sale -75000.00 Adawi Kamal
2024-02-22 Sale -175000.00 ABALLI JOHN

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 60 Aug 05, 2024
8-k 8K-related 15 Aug 05, 2024
8-k 8K-related 17 Aug 02, 2024
8-k/a 8K-related 13 Aug 02, 2024
3 Insider transactions 2 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.